Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only

Y K O Teng; E F Schippers; P W Wijermans

doi:10.1007/s12185-011-0859-y

Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only

Int J Hematol. 2011 Jun;93(6):811-814. doi: 10.1007/s12185-011-0859-y. Epub 2011 May 11.

Authors

Y K O Teng¹, E F Schippers², P W Wijermans²

Affiliations

¹ Department of Internal Medicine, HagaZiekenhuis, The Hague, The Netherlands. y.k.o.teng@lumc.nl.
² Department of Internal Medicine, HagaZiekenhuis, The Hague, The Netherlands.

PMID: 21557043
DOI: 10.1007/s12185-011-0859-y

Abstract

The present report describes repeated long-term remissions of a high-grade T cell lymphoma in an HIV-positive patient upon cART only, without additional chemotherapy. A review of cases from the literature further illustrates the anti-tumor effects of cART through the induction of a strong immune reconstitution in HIV-infected patients.

Publication types

Case Reports
Review

MeSH terms

Anti-HIV Agents / therapeutic use*
Antiretroviral Therapy, Highly Active
Bone and Bones / pathology
CD4 Lymphocyte Count
HIV Infections / complications
Humans
Lymphoma, AIDS-Related / diagnosis
Lymphoma, AIDS-Related / drug therapy*
Lymphoma, AIDS-Related / pathology*
Lymphoma, T-Cell / diagnosis
Lymphoma, T-Cell / drug therapy*
Lymphoma, T-Cell / pathology*
Male
Middle Aged
Neoplasm Staging
Positron-Emission Tomography
Tomography, X-Ray Computed
Treatment Outcome
Viral Load

Substances

Anti-HIV Agents